591169 Disclosed is the use of the compound (S)-N-[[3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide (Formula I) or a pharmaceutically acceptable salt thereof in combination with at least two anti-tuberculin agents selected from rifampin isoniazid moxifloxacin and pyrazinamide in the manufacture of a medicament for the treatment of tuberculosis.

暂无附图